Healthcare Triangle Shares Surge on AI Agent Launch

Dow Jones03-26
 

By Elias Schisgall

 

Shares of Healthcare Triangle surged after the company launched an artificial-intelligence agent for customer engagement.

Shares were up 36% to $3.98 in after-hours trading on Wednesday, after closing up 11% at $2.92. At the close, the stock had fallen 98% over the past six months.

The healthcare and life sciences technology company said Wednesday that it deployed an agentic AI tool on Teyame AI's customer engagement platform. Healthcare Triangle inked a deal in January to acquire Teyame AI, a Spain-based AI customer service company.

It said Wednesday that it hopes to scale the agentic AI capabilities across the U.S. and Latin America following Teyame's success in Spain.

The AI agent is able to automate human-like customer service conversations at scale, with security and regulatory compliance built in, the company said.

"I am excited that HCTI is at the cutting edge of Agentic.AI integration and will be able to roll it out across multiple languages in new geographies and accelerate our growth over next few years," Healthcare Triangle Chief Financial Officer David Ayanoglou said.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

March 25, 2026 17:48 ET (21:48 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment